Caltech/UCLA Individualized Theranostic Engineering to Advance Metabolic System (iTEAM)

加州理工学院/加州大学洛杉矶分校个性化治疗诊断工程促进代谢系统 (iTEAM)

基本信息

  • 批准号:
    10213026
  • 负责人:
  • 金额:
    $ 29.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-07-08 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

ABSTRACT The California Institute of Technology (Caltech) and the University of California at Los Angeles (UCLA) have partnered to integrate advanced imaging and sensing coupled with computing needed to translate technological innovation to address the global cardiometabolic disease. The UCLA/Caltech integrated Theranostic Engineering to Advance Metabolic Medicine (iTEAM) Program represents a new paradigm that will be formalized into a 2-year, structured curriculum with an emphasis on recruiting the under-represented post-doctoral engineers or physical scientists into leadership roles in academia and industry. The convergence of the fundamental strengths of Caltech and clinical strengths of UCLA is conducive to individualize training in 1) advanced sensing or 2) imaging coupled with computing to address 3) cardiometabolic disease. The iTEAM program is partnering with industry leaders (Amgen, Johnson & Johnson, Medtronic, and Edwards Lifesciences) for internship, mentorship, and leadership programs. Both the Caltech Diversity Center and UCLA Faculty Diversity & Development Office have supported workshops on Science Technology Engineering & Mathematics (STEM) for women and underrepresented minorities. To implement this UCLA/Caltech iTEAM program, we have developed a mentoring and self-evaluating structure in the inclusion of 21 primary and co-mentors, 13 consulting mentors, and 10 industry leaders (42% female). Each iTEAM scholar will have co-mentorships: a primary mentor from enabling technologies and a secondary from cardiometabolic medicine and/or industry. In Year 1, iTEAM scholars will: 1) Participate in an initial two- day workshop including mentors, program leaders, clinicians, physician-scientists, and industry leaders to explore projects, expectations, mentorship, and goals; 2) Meet one-to-one with the Program Director(s) to finalize a primary (imaging or sensing) and a co-mentor (cardiometabolic disease or industry); 3) Develop an Individualized Development Plans (IDP) with the Advising & Training Committee to finalize the project; and 4) Strengthen fundamental knowledge in advanced imaging, sensors, or computation and didactic training for ethics in biomedical research and publications. In Year 2, iTEAM scholars will be afforded 1) the opportunity to present work-in-progress and provide feedback in quarterly meetings with a primary mentor and with a co- mentor, 2) an option to participate in a certificate in Pathways in Clinical and Translational Research from the UCLA Clinical Translational Science Institute (CTSI) or Law and Technology for FDA regulatory science (BE188/299); and/or 3) to participate in UCLA CTSI-sponsored professional development in preparation for an academic or industry career. Both Caltech and UCLA Deans have committed matching funds for each iTEAM scholar. UCLA Vice Provost for Graduate Education and has also committed supplemental trainee support to enhance the diversity of trainees. Overall, this program infuses the scientific workforce with the next generation of theranostic bioengineers prepared to solve the worldwide threat of cardiometabolic disease.
摘要 加州理工学院(Caltech)和位于洛杉矶的加州大学(UCLA)已经 合作将先进的成像和传感技术与所需的计算技术相结合, 技术创新,以解决全球心脏代谢疾病。加州大学洛杉矶分校/加州理工学院综合 治疗诊断工程推进代谢医学(iTEAM)计划代表了一种新的范式, 将正式成为一个2年,结构化的课程,重点是招聘代表性不足 博士后工程师或物理科学家进入学术界和工业界的领导角色。的 加州理工学院的基本优势和加州大学洛杉矶分校的临床优势的融合有利于 在1)高级感知或2)成像与计算方面进行个性化培训,以解决3) 心脏代谢疾病iTEAM计划与行业领导者(安进、约翰逊和 约翰逊、美敦力和Edwards Lifesciences)的实习、指导和领导力计划。两者 加州理工学院多元化中心和加州大学洛杉矶分校教师多元化与发展办公室支持举办研讨会, 科学技术工程和数学(STEM)为妇女和代表性不足的少数民族。到 为了实施UCLA/Caltech iTEAM计划,我们开发了一个指导和自我评估结构, 包括21名主要和共同导师、13名咨询导师和10名行业领导者(42%为女性)。 每个iTEAM学者将有共同导师:一个主要的导师从使能技术和第二个 心脏代谢医学和/或工业。在第一年,iTEAM学者将:1)参加最初的两个- 为期一天的研讨会,包括导师,项目负责人,临床医生,医生,科学家和行业领导者, 探索项目、期望、指导和目标; 2)与项目总监一对一会面, 最终确定主要(成像或传感)和共同导师(心脏代谢疾病或行业); 3)制定 与咨询和培训委员会一起制定个性化发展计划,以最终确定项目;以及4) 加强先进成像、传感器或计算的基础知识, 生物医学研究和出版物中的伦理学。在第二年,iTEAM学者将获得1)机会, 在与主要导师和共同导师的季度会议上展示正在进行的工作并提供反馈, 导师,2)参加临床和转化研究途径证书的选项 加州大学洛杉矶分校临床转化科学研究所(CTSI)或FDA监管科学法律与技术 (BE 188/299);和/或3)参加加州大学洛杉矶分校CTSI赞助的专业发展,为 学术或工业生涯。加州理工学院和加州大学洛杉矶分校的院长都承诺为每个iTEAM提供配套资金 学者加州大学洛杉矶分校研究生教育副教务长,并承诺补充实习生的支持, 加强学员的多样性。总的来说,这个项目为下一代科学工作者注入了活力。 治疗诊断学生物工程师准备解决心脏代谢疾病的全球威胁。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dino Di Carlo其他文献

Dino Di Carlo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Dino Di Carlo', 18)}}的其他基金

Hydrogel nanovial technology for single-cell sorting based on extracellular vesicle production
基于细胞外囊泡产生的单细胞分选水凝胶纳米瓶技术
  • 批准号:
    10411907
  • 财政年份:
    2021
  • 资助金额:
    $ 29.19万
  • 项目类别:
Enhancing the potency of mesenchymal stem cell therapies for kidney diseases using lab-on-a-particle technology
使用粒子实验室技术增强间充质干细胞治疗肾脏疾病的效力
  • 批准号:
    10373803
  • 财政年份:
    2021
  • 资助金额:
    $ 29.19万
  • 项目类别:
Lab on a particle technology for functional screening of therapeutic cells
用于治疗细胞功能筛选的粒子技术实验室
  • 批准号:
    10272940
  • 财政年份:
    2021
  • 资助金额:
    $ 29.19万
  • 项目类别:
Hydrogel nanovial technology for single-cell sorting based on extracellular vesicle production
基于细胞外囊泡产生的单细胞分选水凝胶纳米瓶技术
  • 批准号:
    10193200
  • 财政年份:
    2021
  • 资助金额:
    $ 29.19万
  • 项目类别:
Caltech/UCLA Individualized Theranostic Engineering to Advance Metabolic System (iTEAM)
加州理工学院/加州大学洛杉矶分校个性化治疗诊断工程促进代谢系统 (iTEAM)
  • 批准号:
    10440285
  • 财政年份:
    2020
  • 资助金额:
    $ 29.19万
  • 项目类别:
Caltech/UCLA Individualized Theranostic Engineering to Advance Metabolic System (iTEAM)
加州理工学院/加州大学洛杉矶分校个性化治疗诊断工程促进代谢系统 (iTEAM)
  • 批准号:
    10683974
  • 财政年份:
    2020
  • 资助金额:
    $ 29.19万
  • 项目类别:
Training the next generation of leaders in biomedical engineering design
培训下一代生物医学工程设计领导者
  • 批准号:
    10599275
  • 财政年份:
    2019
  • 资助金额:
    $ 29.19万
  • 项目类别:
Training the next generation of leaders in biomedical engineering design
培训下一代生物医学工程设计领导者
  • 批准号:
    10428473
  • 财政年份:
    2019
  • 资助金额:
    $ 29.19万
  • 项目类别:
Engineering Yeast towards High Titer Production of Monoterpene Indole Alkaloid Natural Products
工程酵母用于高滴度生产单萜吲哚生物碱天然产物
  • 批准号:
    10735587
  • 财政年份:
    2018
  • 资助金额:
    $ 29.19万
  • 项目类别:
Force phenotyping of airway smooth muscle cells to develop novel asthma therapies
强制气道平滑肌细胞表型分析以开发新型哮喘疗法
  • 批准号:
    9452964
  • 财政年份:
    2017
  • 资助金额:
    $ 29.19万
  • 项目类别:

相似国自然基金

相似海外基金

Elucidation of metabolic control mechanism by FGF21-mediated central nervous system signaling in neonatal period
阐明新生儿期 FGF21 介导的中枢神经系统信号传导的代谢控制机制
  • 批准号:
    23K10836
  • 财政年份:
    2023
  • 资助金额:
    $ 29.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Re-wiring the metabolic regulatory system to promote a healthy ageing trajectory
重新连接代谢调节系统以促进健康的衰老轨迹
  • 批准号:
    EP/Y027892/1
  • 财政年份:
    2023
  • 资助金额:
    $ 29.19万
  • 项目类别:
    Fellowship
Glial metabolic status regulates axon regeneration in the central nervous system
神经胶质代谢状态调节中枢神经系统轴突再生
  • 批准号:
    10656678
  • 财政年份:
    2023
  • 资助金额:
    $ 29.19万
  • 项目类别:
NUTRITION-RESPONSIVENESS OF THE IMMUNE SYSTEM: INTERPLAY BETWEEN INFECTIOUS DISEASES AND DIET-RELATED METABOLIC DISEASES AND THE POTENTIAL...
免疫系统的营养反应:传染病和饮食相关代谢疾病之间的相互作用以及潜在的...
  • 批准号:
    MR/X031373/1
  • 财政年份:
    2023
  • 资助金额:
    $ 29.19万
  • 项目类别:
    Research Grant
Investigation of the Role of Reactive Sulfur Synthase System (CBS/CSE/3MST system) in the Pathogenesis of Metabolic Syndrome by using CBS/CSE/3MST-deficient Mice.
使用 CBS/CSE/3MST 缺陷小鼠研究活性硫合酶系统(CBS/CSE/3MST 系统)在代谢综合征发病机制中的作用。
  • 批准号:
    23K19485
  • 财政年份:
    2023
  • 资助金额:
    $ 29.19万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Metabolic/gas exchange system
代谢/气体交换系统
  • 批准号:
    10629673
  • 财政年份:
    2023
  • 资助金额:
    $ 29.19万
  • 项目类别:
Temperature and metabolic compensation mechanisms in a circadian clock system
生物钟系统中的温度和代谢补偿机制
  • 批准号:
    10544006
  • 财政年份:
    2022
  • 资助金额:
    $ 29.19万
  • 项目类别:
Metabolic Material System: Material Growth by Metabolic-like Destruction and Remodeling
代谢物质系统:通过类代谢破坏和重塑实现物质生长
  • 批准号:
    22H04968
  • 财政年份:
    2022
  • 资助金额:
    $ 29.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Collaborative Research: Detecting Gait Phases with Raised Metabolic Cost using Robotic Perturbations and System Identification for Enabling Targeted Rehabilitation Therapy
合作研究:使用机器人扰动和系统识别来检测代谢成本升高的步态阶段,以实现有针对性的康复治疗
  • 批准号:
    2203144
  • 财政年份:
    2022
  • 资助金额:
    $ 29.19万
  • 项目类别:
    Standard Grant
Metabolic interactions between tumor cells and the immunce system in GBM A potential Achilles heel of GBM for novel therapeutics
GBM 中肿瘤细胞与免疫系统之间的代谢相互作用是 GBM 新疗法的潜在致命弱点
  • 批准号:
    10522529
  • 财政年份:
    2022
  • 资助金额:
    $ 29.19万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了